Literature DB >> 30464726

Epilepsy and Alzheimer's Disease: Ubiquitous Entities Subject to the Same Cosmic Forces but on Different Astral Planes.

Cynthia L Harden.   

Abstract

Entities:  

Year:  2018        PMID： 30464726      PMCID： PMC6224137          DOI： 10.5698/1535-7597.18.5.295

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  18 in total

1.  Seizures and epileptiform activity in the early stages of Alzheimer disease.

Authors:  Keith A Vossel; Alexander J Beagle; Gil D Rabinovici; Huidy Shu; Suzee E Lee; Georges Naasan; Manu Hegde; Susannah B Cornes; Maya L Henry; Alexandra B Nelson; William W Seeley; Michael D Geschwind; Maria L Gorno-Tempini; Tina Shih; Heidi E Kirsch; Paul A Garcia; Bruce L Miller; Lennart Mucke
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

2.  Association of apolipoprotein E ε4 allele with cognitive impairment in patients with epilepsy and interaction with phenytoin monotherapy.

Authors:  A Palanisamy; N N Rajendran; M P Narmadha; R A Ganesvaran
Journal:  Epilepsy Behav       Date:  2012-12-27       Impact factor: 2.937

3.  Effect of apolipoprotein ε4 allele on hippocampal and brain volume in intractable temporal lobe epilepsy.

Authors:  Robyn M Busch; Darlene Floden; Tara T Lineweaver; Jessica S Chapin; Kanjana Unnwongse; Tim Wehner; Ramon Diaz-Arrastia; Imad M Najm
Journal:  Epilepsy Behav       Date:  2011-02-12       Impact factor: 2.937

4.  ApoE epsilon4 genotype and the age at onset of temporal lobe epilepsy: a case-control study and meta-analysis.

Authors:  Marcelo Andrés Kauffman; Damián Consalvo; Dolores Gonzalez Moron; Virginia Pujol Lereis; Silvia Kochen
Journal:  Epilepsy Res       Date:  2010-06-15       Impact factor: 3.045

5.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.

Authors:  Keith A Vossel; Kamalini G Ranasinghe; Alexander J Beagle; Danielle Mizuiri; Susanne M Honma; Anne F Dowling; Sonja M Darwish; Victoria Van Berlo; Deborah E Barnes; Mary Mantle; Anna M Karydas; Giovanni Coppola; Erik D Roberson; Bruce L Miller; Paul A Garcia; Heidi E Kirsch; Lennart Mucke; Srikantan S Nagarajan
Journal:  Ann Neurol       Date:  2016-11-07       Impact factor: 10.422

6.  ApoE-epsilon4 is associated with reduced memory in long-standing intractable temporal lobe epilepsy.

Authors:  R M Busch; T T Lineweaver; R I Naugle; K H Kim; Y Gong; C Q Tilelli; R A Prayson; W Bingaman; I M Najm; R Diaz-Arrastia
Journal:  Neurology       Date:  2007-02-06       Impact factor: 9.910

7.  Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.

Authors:  T Gomez-Isla; H L West; G W Rebeck; S D Harr; J H Growdon; J J Locascio; T T Perls; L A Lipsitz; B T Hyman
Journal:  Ann Neurol       Date:  1996-01       Impact factor: 10.422

8.  Tau reduction prevents disease in a mouse model of Dravet syndrome.

Authors:  Ania L Gheyara; Ravikumar Ponnusamy; Biljana Djukic; Ryan J Craft; Kaitlyn Ho; Weikun Guo; Mariel M Finucane; Pascal E Sanchez; Lennart Mucke
Journal:  Ann Neurol       Date:  2014-08-13       Impact factor: 10.422

9.  Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections.

Authors:  Xin You Tai; Matthias Koepp; John S Duncan; Nick Fox; Pamela Thompson; Sallie Baxendale; Joan Y W Liu; Cheryl Reeves; Zuzanna Michalak; Maria Thom
Journal:  Brain       Date:  2016-08-07       Impact factor: 13.501

10.  Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss.

Authors:  J Di; L S Cohen; C P Corbo; G R Phillips; A El Idrissi; A D Alonso
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379
View more
  1 in total

1.  Bi-directional association between epilepsy and dementia: The Framingham Heart Study.

Authors:  Maria Stefanidou; Alexa S Beiser; Jayandra Jung Himali; Teng J Peng; Orrin Devinsky; Sudha Seshadri; Daniel Friedman
Journal:  Neurology       Date:  2020-10-23       Impact factor: 9.910
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.